ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹12 Cr | ₹0.11 Cr | ₹-8.27 Cr | ₹-6.36 Cr | ₹-1.59 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹-8.27 Cr |
| Mar2023 | ₹-6.36 Cr |
| Mar2022 | ₹-1.59 Cr |
How is Cash Flow from Financing Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | 10,738.18 | |
| Mar2025 | ₹0.11 Cr | Positive | |
| Mar2024 | ₹-8.27 Cr | Negative | |
| Mar2023 | ₹-6.36 Cr | Negative | |
| Mar2022 | ₹-1.59 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹447.5 Cr | -0.8% | -2.4% | -9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0.8% |
-2.4% |
-9.4% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses